First Capital Advisors Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,763
| Closed | -$265K | – | 180 |
|
|
2018
Q3 | $265K | Sell |
2,763
-200
| -7% | -$19.2K | 0.16% | 129 |
|
|
2018
Q2 | $282K | Sell |
2,963
-1,263
| -30% | -$120K | 0.19% | 122 |
|
|
2018
Q1 | $371K | Sell |
4,226
-1,026
| -20% | -$90.1K | 0.21% | 89 |
|
|
2017
Q4 | $446K | Buy |
5,252
+853
| +19% | +$72.4K | 0.28% | 93 |
|
|
2017
Q3 | $381K | Sell |
4,399
-4,899
| -53% | -$424K | 0.26% | 99 |
|
|
2017
Q2 | $718K | Sell |
9,298
-1,390
| -13% | -$107K | 0.49% | 60 |
|
|
2017
Q1 | $741K | Buy |
10,688
+4,099
| +62% | +$284K | 0.55% | 54 |
|
|
2016
Q4 | $390K | Buy |
+6,589
| New | +$390K | 0.36% | 84 |
|